{"id":157266,"date":"2023-02-07T17:25:43","date_gmt":"2023-02-07T23:25:43","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/02\/lixte-biotechnology-holdings-inc-reports-that-its-lead-clinical-compound-lb-100-can-kill-cancer-cells-through-hyper-stimulation-of-cell-proliferation-signals-in-pre-clinical-models"},"modified":"2023-02-07T17:25:43","modified_gmt":"2023-02-07T23:25:43","slug":"lixte-biotechnology-holdings-inc-reports-that-its-lead-clinical-compound-lb-100-can-kill-cancer-cells-through-hyper-stimulation-of-cell-proliferation-signals-in-pre-clinical-models","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/02\/lixte-biotechnology-holdings-inc-reports-that-its-lead-clinical-compound-lb-100-can-kill-cancer-cells-through-hyper-stimulation-of-cell-proliferation-signals-in-pre-clinical-models","title":{"rendered":"Lixte Biotechnology Holdings, Inc. Reports That Its Lead Clinical Compound, Lb-100, Can Kill Cancer Cells Through Hyper-Stimulation of Cell Proliferation Signals in Pre-Clinical Models"},"content":{"rendered":"<p><a class=\"blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/lixte-biotechnology-holdings-inc-reports-that-its-lead-clinical-compound-lb-100-can-kill-cancer-cells-through-hyper-stimulation-of-cell-proliferation-signals-in-pre-clinical-models.jpg\"><\/a><\/p>\n<p>\u2014THE STUDY ESTABLISHES A NOVEL CONCEPT OF \u201cTUMOR SUPPRESSIVE DRUG RESISTANCE\u201d<\/p>\n<p>\u2014THE COMBINATION OF LB-100 WITH INHIBITORS OF CELLULAR STRESS RESPONSE MODULATORS WAS HIGHLY EFFECTIVE IN KILLING CANCER CELLS IN SEVERAL PRE-CLINICAL CANCER MODELS<\/p>\n<p>\u2014RESISTANCE TO THIS THERAPY CAN RESULT IN THE LOSS OF THE ONCOGENIC PROPERTIES OF CANCER CELLS<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u2014THE STUDY ESTABLISHES A NOVEL CONCEPT OF \u201cTUMOR SUPPRESSIVE DRUG RESISTANCE\u201d \u2014THE COMBINATION OF LB-100 WITH INHIBITORS OF CELLULAR STRESS RESPONSE MODULATORS WAS HIGHLY EFFECTIVE IN KILLING CANCER CELLS IN SEVERAL PRE-CLINICAL CANCER MODELS \u2014RESISTANCE TO THIS THERAPY CAN RESULT IN THE LOSS OF THE ONCOGENIC PROPERTIES OF CANCER CELLS<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-157266","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/157266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=157266"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/157266\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=157266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=157266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=157266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}